Search
for
Sort by
Research 181–210 of 526
- Topical agents for hair growth promotion: what is out there?
- A failure to relax.
- By the way, doctor. I don't hear nearly as much about hair loss in women as in men. But I'm 65 and have watched my hair thin considerably over the past five or six years. Is there anything I can do about it? What about Rogaine?
- I think I'm losing my hair.
- [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
- Male pattern baldness.
- [The effect of nutritional deficiency on hair roots (trichogram)].
- [A case report of Cushing's syndrome due to an adrenal carcinoma].
- [Adverse drug reactions on hair].
- [Preliminary findings on lectin binding in human follicular epithelium].
- [Difference between the hair follicle cell and epidermal keratinocyte in vitro].
- [Usefulness and limitations of the evaluation of sex-hormone-binding globulin in women with a female pattern of androgen-induced baldness].
- Effect of contraceptives on the skin.
- Androgenic alopecia.
- [Contraceptive methods for adolescents].
- Telogen effluvium: hair loss after spinal cord injury.
- [Dermatologic indications for anti-androgenic treatment].
- [Reactions and side effects of ovulation inhibitors on the skin].
- [A new treatment for androgenetic alopecia : platelet-rich plasma injections].
- Autologous Platelet-Rich Plasma in the treatment of androgenetic alopecia: results of a 54-patient prospective study
- Autologous Platelet-Rich Plasma in the Treatment of Androgenetic Alopecia: Results of a 54-Patient Prospective Study.
- Microneedling and Platelet-Rich Plasma versus Microneedling and 5% Topical Minoxidil Therapy in Male Pattern Hair Loss.
- Microneedling and Platelet-Rich Plasma versus Microneedling and 5% Topical Minoxidil Therapy in Male Pattern Hair Loss.
- [Androgenetic alopecia in women].
- Social selection favours offspring prone to the development of androgenetic alopecia.
- [Endocrine constellation in androgenetic alopecia in the female].
- Serum testosterone and sex hormone binding globulin levels in women with androgenetic alopecia.
- BPH: epidemiology and comorbidities.
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.